As the BIO annual meeting wraps up its final day, plenty of things are still going on with participants discussing the value of R&D, as well as the deals in the headlines. Meanwhile, J&J announces a slew of tie-ups conducted through its Innovation Centers.

Venture capitalists tell START-UP’s annual survey that seeing will be believing when it comes to the potential of single-asset models. Plus news on recent financings by iPierian, Evotec, ObsEva and Acacia.

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.